Andrea Apollo, M.D.

Andrea Apolo discusses why patients are never forgotten

Nov 18, 2016

Andrea Apolo, Investigator in the Genitourinary Malignancies Branch and Head of the Bladder Cancer Section, reflects on her clinical trial patients in the Bladder Cancer Advocacy Network's fall newsletter . She says: "Every time I use data derived from a patient in one of our clinical trials, I think about them; I think about their family, their loved ones. I remember the conversations we had while they were in clinic about politics, travel and the hobbies they enjoyed. I have memories of hundreds of study patients, and I am very grateful to each of them for their altruistic contribution to my research."

Andrea Apolo discusses why patients are never forgotten

Clinical Research Center welcomes first-ever National Cancer Reporting Fellowship

Nov 18, 2016

The first-ever National Cancer Reporting Fellowship came to the NCI this fall for a 4-day workshop designed to improve how the media reports on cancer research and give fellows an opportunity to interact with the people they report on. During their tour of the Clinical Research Center, the fellows heard from CCR investigators James Gulley, M.D., Ph.D., Christian Hinrichs, M.D., and Peter Choyke, M.D., F.A.C.R.   Learn more...

 

 

Clinical Research Center welcomes first-ever National Cancer Reporting Fellowship

Lori Wiener discusses psychosocial impacts of childhood cancers

Nov 14, 2016

Lori Wiener, co-director of the Behavioral Health Core and head of the Psychosocial Support and Research Program, was quoted in HemOnc Today on the evolution of psychosocial care for cancer patients. She says that providing psychosocial care to patients can help improve their overall care. “We have to communicate information to pediatric patients in a way that is truthful and developmentally appropriate, and we need to be able to include them in medical decision-making in an age-appropriate way,” she says. “Providing family centered care is essential. The diagnosis of cancer in a child is a life-changing event for everyone in the family and attention to ongoing parental and family needs is required for optimal psychosocial care to be provided.”

Lori Wiener discusses psychosocial impacts of childhood cancers
pancreatic cancer cells

Pancreatic Cancer Awareness Month

Nov 1, 2016

November is Pancreatic Cancer Awareness Month, and we are recognizing the month by highlighting our researchers and their discoveries in the pancreatic cancer field.  Learn more...

MPNST state of the science: outlining a research agenda for the future

Oct 27, 2016

In October 2016, clinicians and scientists from around the world gathered on the NIH campus to exchange ideas on the future of malignant peripheral nerve sheath tumor (MPNST) research. Learn more...

Over 200 people attended the first Cancer Health Disparities Interest Group Research Symposium on October 18th

Oct 25, 2016

The causes of cancer health disparities are multi-faceted and the approaches needed to understand and overcome them are multi-disciplinary.  Learn more...

Christina Annunziata discusses PARP inhibitors with STAT

Oct 17, 2016

Christina Annunziata, Investigator in the Women’s Malignancies Branch, spoke with STAT about PARP inhibitors, a new class of drugs for ovarian cancer treatment. She has studied the efficacy of Lynparza, a PARP inhibitor, and says more clinical trials using PARP inhibitors with other cancer treatments will become more prevalent. Learn more...

Christina Annunziata discusses PARP inhibitors with STAT
computer monitor showing HeLa cells

CCR investigator describes the use of HeLa cells in cancer research

Oct 5, 2016

Henrietta Lacks’ cells have been used around the world since the 1950s and have helped with developing the polio vaccine, gene mapping, cancer research and understanding how to grow cells in the lab. Stadtman Investigator Jadranka Loncarek from the Laboratory of Protein Dynamics and Signaling discussed how she uses HeLa cells in her research with WHAG.

CCR investigator describes the use of HeLa cells in cancer research
Ava Christianson at the playground

8-year-old girl in remission after immunotherapy clinical trial

Oct 5, 2016

8-year-old Ava Christianson’s acute lymphoblastic leukemia has relapsed five times. She is currently in remission after participating in a CAR T-cell therapy clinical trial under the care of physician-scientist Dr. Terry Fry of the Pediatric Oncology Branch.

8-year-old girl in remission after immunotherapy clinical trial
little boy wearing large sunglasses

CCR celebrates Childhood Cancer Awareness Month

Oct 5, 2016

Throughout September, we featured our Pediatric Oncology Branch with research advances, resources, patients and families. We’ve recapped our coverage in this Storify post.

CCR celebrates Childhood Cancer Awareness Month

Pages